论文部分内容阅读
目的:分析红花黄色素对急性多发性腔隙性脑梗死的临床治疗效果。方法:我院2011年6月-2015年4月期间共收治急性多发性腔隙性脑梗死患者160例,随机将其分为对照组与观察组,对照组80例患者运用血栓通治疗,观察组80例患者运用红花黄色素治疗,对比两组患者的临床疗效。结果:对照组的60例患者中,痊愈10例,占16.67%,显效20例,占33.33%,有效8例,占13.33%,临床治疗总有效率为63.33%,观察组的60例患者中,痊愈18例,占30%,显效26例,占43.33%,有效10例,占16.67%,临床治疗总有效率为90.00%,观察组患者的临床疗效明显优于对照组患者,差异具有统计学意义(P<0.05)。结论:运用红花黄色素对急性多发性腔隙性脑梗死患者进行治疗疗效确切。
Objective: To analyze the clinical effect of safflor yellow on acute multiple lacunar infarction. Methods: From June 2011 to April 2015, 160 patients with acute multiple lacunar infarction were treated in our hospital from June 2011 to April 2015. They were randomly divided into control group and observation group. 80 patients in control group were treated with Xueshuantong. Group 80 patients treated with safflower yellow, compared the clinical efficacy of two groups of patients. Results: Among the 60 patients in the control group, 10 cases were cured, accounting for 16.67%, 20 cases were markedly effective (33.33%), 8 were effective (13.33%), and the total effective rate was 63.33% , Cured 18 cases, accounting for 30%, markedly effective in 26 cases, accounting for 43.33%, effective in 10 cases, accounting for 16.67%, the total effective rate of clinical treatment was 90.00%, the clinical efficacy of observation group was significantly better than the control group, the difference was statistically Significance (P <0.05). Conclusion: The use of safflower yellow pigment in patients with acute multiple lacunar infarction is effective.